Module13. Gene Therapy
Module13. Gene Therapy
Gene Therapy
INTRODUCTION
In the field of medicine, medical researchers are continuously looking for different
ways of treating genetic disorders and gene-related illnesses. With the advent of molecular
biology, the causes of genetic disorders were now being traced and defective genes are
now detected. A deeper understanding of the molecular components of the body such as
genes, their functions, locations and control mechanisms paved way for coming up of a
clearer technique in treating disorders. These ushered the development of treating genetic
disorders called gene therapy. The initial aim of gene therapy was the correction of
inherited genetic diseases.
After completing the module, you should be able to answer the question:
What are potential benefits and issues of gene therapy on health?
LEARNING OBJECTIVES
LEARNING CONTENT
Gene therapy is when a DNA is introduced into a patient to treat a genetic disease.
The new DNA contains a functioning gene to correct the effects of a disease causing
mutation. It is also an experimental technique that uses genes to treat or prevent disease.
This technique may allow doctors to treat a disorder by inserting a gene into a patient’s
cells instead of using drugs or surgery.
Gene therapy is designed to introduce genetic material into cells to compensate for
abnormal genes or to make a beneficial protein. If a mutated gene causes a necessary
protein to be faulty or missing, gene therapy may be able to introduce a normal copy of the
gene to restore the function of the protein.
A gene that is inserted directly into a cell usually does not function. Instead, a carrier
called a vector is genetically engineered to deliver the gene. Certain viruses are often used
as vectors because they can deliver the new gene by infecting the cell. The viruses are
modified so they can't cause disease when used in people. Some types of virus, such as
retroviruses, integrate their genetic material (including the new gene) into a chromosome in
the human cell. Other viruses, such as adenoviruses, introduce their DNA into the nucleus
of the cell, but the DNA is not integrated into a chromosome.
The vector can be injected or given intravenously (by IV) directly into a specific
tissue in the body, where it is taken up by individual cells. Alternately, a sample of the
patient's cells can be removed and exposed to the vector in a laboratory setting. The cells
containing the vector are then returned to the patient. If the treatment is successful, the new
gene delivered by the vector will make a functioning protein.
Researchers must overcome many technical challenges before gene therapy will be a
practical approach to treating disease. For example, scientists must find better ways to
deliver genes and target them to particular cells. They must also ensure that new genes are
precisely controlled by the body.
A new gene is inserted directly into a cell. A carrier called a vector is genetically
engineered to deliver the gene. An adenovirus introduces the DNA into the nucleus of the
cell, but the DNA is not integrated into a chromosome.
1. Somatic gene therapy – transfer of a section of DNA to any cell of the body that
doesn’t produce sperm or eggs.
2. Germline gene therapy – transfer of a section of DNA to cells that produces sperm or
eggs.
1. Somatic-Cell gene therapy for the cure and prevention of diseases. Example :
insertion of a DNA sequence into a person’s cell to allow production of an enzyme
like adenosine deaminase.
2. Germ Line gene therapy for cure and prevention of diseases. Example: Insertion of
an adenosine deaminase sequence into early embryo or reproductive cells, which
would affect not only the individual but all of his or her offspring.
3. Somatic cell enhancement. Example: Insertion of a DNA sequence to improve
memory , increase height, or increase intelligence which would affect only the
individual.
4. Germ line enhancement. Example: Insertion of a DNA sequence for enhancement
into a blastocyst, sperm or egg, which would affect future generation.
There are several ways by which gene therapy is administered. This includes the
following:
2.Gene inhibition therapy. This is suitable for the treatment of infectious diseases, cancer
and inherited diseases caused by the inappropriate gene activity. The aim is to introduce a
gene whose product either: inhibits the expression of another gene or interferes with the
activity of the product of another gene.
3. Gene therapy killing of specific cells. Genes are directed to the target cells and then
expressed so as to cause cell killing. Direct cell killing is possible if the inserted genes are
expressed to produce a lethal toxin(suicide gene) or a gene encoding a prodrug is inserted,
conferring susceptibility to killing by a subsequently administered drug.
The growing popularity of gene therapy earned much attention from all over the
world such that, other possible applications of this technique is being explored through
researches just like enhancement of height, intelligence, athletic ability, address infertility
and also its use in the field of cosmetology.
Although gene therapy has promising results, we always asked the question, “Do the
potential benefits of gene therapy outweigh the potential risks?
READ
List down the diseases/disorders that can be treated by Gene Therapy using the table
below. Submit your output in word or PDF format at ______________________.
2. Polygenic Disorders
3. Infectious Diseases
At present, the type of therapy being undertaken is somatic gene therapy where the
DNA is inserted to a somatic cell and is not passed on to the offspring. Germline therapy on
the other hand, the DNA is inserted into a reproductive cell in which it can be passed on to
the offspring. The controversy lies in the latter type since the affected individuals are the
unborn ones who will be experiencing the unexpected consequences of the technique. The
following are some ethical questions surrounding gene therapy (Genetics Home Reference,
2017).
Many controversial issues arise on gene therapy and the government of United
States does not fund research studies on human germline gene therapy.
Position Paper. Make a clear stand if you would allow yourself for gene
therapy without its 100% assurance of effectiveness or future negative side effect. Write
your output in word or pdf format and be sure to submit it on __________________ at
_______________or email it at _______________________________________________.
ASSESSMENT TASK
Direction: Read carefully the presented case below and answer the questions that
follow. Write your output in word or pdf format and be sure to submit it on __________ at
_______________ or email it at _________________________________.
Kelly is a 21 year-old college student who is applying for medical school in the very
near future. Her academic history is strong but not exceptional. For this reason, Kelly fears
that she will not be accepted to the top medical schools. Kelly wants to attend medical
school so she can help underserved populations and work in impoverished areas that lack
good healthcare. She tells Dr. Anderson that she would like to receive the Alzheimer’s gene
therapy in hopes it will boost her memory and enhance neural function. Kelly believes a
good score on the MCAT will strengthen her application and enable her to fulfill her dream
of providing medical aid to the world’s neediest people.”
Questions:
REFERENCES
Amarille, Anna Theresa M., et. al. 2018. Science, technology and Society. Malabon
City, Mutya Publishing House, Inc.
Bioethics case study: Gene Therapy. Accessed 8 July 2020 at
https://www.asmscience.org/content/book/10.1128/9781555816100.chap40a
Case Study on gene therapy for enhancement purposes. Accessed 8 July 2020 at
https://knowgenetics.org/case-study-gene-therapy-for-enhancement-purposes/
Serafica, J. P. J., Pawilen, G. T., Caslib, B. N. B., & Alata, E. J. P,. Science,
Technology and Society, First Edition 2018, Rex Book Store, Inc. Manila
What are the ethical issues surrounding gene therapy? Accessed 8 July 2020 at
https://ghr.nlm.nih.gov/primer/therapy/ethics